医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Estrogen-dependent depressor response of melatonin via baroreflex afferent function and intensification of PKC-mediated Nav1.9 activation

摘要Recent studies suggest that melatonin(Mel)plays an important role in the regulation of blood pressure(BP)via the aortic baroreflex pathway.In this study,we investigated the interaction between the baroreflex afferent pathway and Mel-mediated BP regulation in rats under physiological and hypertensive conditions.Mel(0.1,0.3,and 1.0 mg/mL)was microinjected into the nodose ganglia(NG)of rats.We showed that Mel-induced reduction of mean arterial pressure in female rats was significantly greater than that in male and in ovariectomized rats under physiological condition.Consistently,the expression of Mel receptors(MTNRs)in the NG of female rats was significantly higher than that of males.In L-NAME-induced hypertensive and spontaneously hypertensive rat models,MTNRs were upregulated in males but downregulated in female models.Interestingly,Mel-induced BP reduction was found in male hypertensive models.In whole-cell recording from identified baroreceptor neurons(BRNs)in female rats,we found that Mel(0.1μM)significantly increased the excitability of a female-specific subpopulation of Ah-type BRNs by increasing the Nav1.9 current density via a PKC-mediated pathway.Similar results were observed in baroreceptive neurons of the nucleus tractus solitarius,showing the facilitation of spontaneous and evoked excitatory post-synaptic currents in Ah-type neurons.Collectively,this study reveals the estrogen-dependent effect of Mel/MTNRs under physiological and hypertensive conditions is mainly mediated by Ah-type BRNs,which may provide new theoretical basis and strategies for the gender-specific anti-hypertensive treatment in clinical practice.

更多
广告
作者 Di Wu [1] Dan Zhao [2] Di Huang [3] Xun Sun [3] Ke-xin Li [3] Yan Feng [3] Qiu-xin Yan [3] Xin-yu Li [3] Chang-peng Cui [3] Hu-die Li [3] Bai-yan Li [3] 学术成果认领
作者单位 Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Medicine Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Department of Pharmacy,The Second Affiliated Hospital of Dalian Medical University,Dalian 116023,China [1] Department of Clinical Pharmacy,The Second Affiliated Hospital of Harbin Medical University,Harbin 150086,China [2] Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Medicine Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China [3]
发布时间 2022-11-03(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
中国药理学报(英文版)

中国药理学报(英文版)

2022年43卷9期

2313-2324页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷